Evidence map›Paper›PMID 26284498›Full record

ArticleeLife2015

A molecular tweezer antagonizes seminal amyloids and HIV infection.

Edina Lump, Laura M Castellano, Christoph Meier, Janine Seeliger, Nelli Erwin, Benjamin Sperlich, Christina M Stürzel, Shariq Usmani, Rebecca M Hammond, Jens von Einem and 20 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Light-Triggered Disassembly of Peptide Nanostructures.Chembiochem : a European journal of chemical biology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM) · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 7 institutions in 2 countries.

Edina LumpInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Laura M CastellanoDepartment of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States.
Christoph MeierInstitute of Organic Chemistry III/Macromolecular Chemistry, Ulm University, Ulm, Germany.
Janine SeeligerPhysical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, Technical University of Dortmund, Dortmund, Germany.
Nelli ErwinPhysical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, Technical University of Dortmund, Dortmund, Germany.
Benjamin SperlichPhysical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, Technical University of Dortmund, Dortmund, Germany.
Christina M StürzelInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Shariq UsmaniInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Rebecca M HammondDepartment of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States.
Jens von EinemInstitute of Virology, Ulm University Medical Center, Ulm, Germany.
Gisa GeroldInstitute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.
Florian KreppelInstitute of Gene Therapy, Ulm University Medical Center, Ulm, Germany.
Kenny Bravo-RodriguezMax-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany.
Thomas PietschmannInstitute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.
Veronica M HolmesDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States.
David PaleschInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Onofrio ZirafiInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Drew WeissmanDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States.
Andrea SowislokDepartment of Chemistry, University of Duisburg-Essen, Essen, Germany.
Burkhard WettigDepartment of Chemistry, University of Duisburg-Essen, Essen, Germany.
Christian HeidDepartment of Chemistry, University of Duisburg-Essen, Essen, Germany.
Frank KirchhoffInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Tanja WeilInstitute of Organic Chemistry III/Macromolecular Chemistry, Ulm University, Ulm, Germany.
Frank-Gerrit KlärnerInstitute of Organic Chemistry, University of Duisburg-Essen, Essen, Germany.
Thomas SchraderDepartment of Chemistry, University of Duisburg-Essen, Essen, Germany.
Gal BitanDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.
Elsa Sanchez-GarciaMax-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany.
Roland WinterPhysical Chemistry I-Biophysical Chemistry, Department of Chemistry and Chemical Biology, Technical University of Dortmund, Dortmund, Germany.
James ShorterDepartment of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, United States.
Jan MünchInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Universität Ulm · DEUniversity of Duisburg-Essen · DEUniversity of Pennsylvania · USTU Dortmund University · DECenter for Experimental and Clinical Infection Research · DEMax-Planck-Institut für Kohlenforschung · DEUniversity of California, Los Angeles · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Amyloid elimination by Hsp104 and substrate-optimized variantsDP2OD002177 · OD · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2007 to 2007
$2.4M
Generating SEVI disaggregases to prevent HIV infectionR21HD074510 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2012 to 2013
$430k
NIAID NIH HHS P30 AI045008NICHD NIH HHS R21 HD074510NICHD NIH HHS R21HD074510NIH HHS DP2 OD002177NIH HHS DP2OD002177NIH HHS P51 OD011132
6 · The paper itself

Abstract

Semen is the main vector for HIV transmission and contains amyloid fibrils that enhance viral infection. Available microbicides that target viral components have proven largely ineffective in preventing sexual virus transmission. In this study, we establish that CLR01, a 'molecular tweezer' specific for lysine and arginine residues, inhibits the formation of infectivity-enhancing seminal amyloids and remodels preformed fibrils. Moreover, CLR01 abrogates semen-mediated enhancement of viral infection by preventing the formation of virion-amyloid complexes and by directly disrupting the membrane integrity of HIV and other enveloped viruses. We establish that CLR01 acts by binding to the target lysine and arginine residues rather than by a non-specific, colloidal mechanism. CLR01 counteracts both host factors that may be important for HIV transmission and the pathogen itself. These combined anti-amyloid and antiviral activities make CLR01 a promising topical microbicide for blocking infection by HIV and other sexually transmitted viruses.

Indexed as

AmyloidAnti-HIV AgentsAntimetabolitesBridged-Ring CompoundsDisease Transmission, InfectiousHIV InfectionsHumansMaleOrganophosphatesSemenAmyloidAnti-HIV AgentsAntimetabolitesBridged-Ring CompoundsCLR01 compoundOrganophosphatesamyloidbiochemistrybiophysicsHIVhumanmolecular tweezerstructural biologyviruses

Identifiers

PMID26284498
PMCPMC4536748
OpenAlexW2170049497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.